Search Results - "CASANOVAS, Oriol"
-
1
Unraveling the Role of Angiogenesis in Cancer Ecosystems
Published in Frontiers in oncology (02-07-2018)“…Activation of the tumor and stromal cell-driven angiogenic program is one of the first requirements in the tumor ecosystem for growth and dissemination. The…”
Get full text
Journal Article -
2
Endothelial cell rearrangements during vascular patterning require PI3-kinase-mediated inhibition of actomyosin contractility
Published in Nature communications (16-11-2018)“…Angiogenesis is a dynamic process relying on endothelial cell rearrangements within vascular tubes, yet the underlying mechanisms and functional relevance are…”
Get full text
Journal Article -
3
Resistance to Antiangiogenic Therapies by Metabolic Symbiosis in Renal Cell Carcinoma PDX Models and Patients
Published in Cell reports (Cambridge) (10-05-2016)“…Antiangiogenic drugs are used clinically for treatment of renal cell carcinoma (RCC) as a standard first-line treatment. Nevertheless, these agents primarily…”
Get full text
Journal Article -
4
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Published in Cancer cell (03-03-2009)“…Multiple angiogenesis inhibitors have been therapeutically validated in preclinical cancer models, and several in clinical trials. Here we report that…”
Get full text
Journal Article -
5
PTEN mediates Notch-dependent stalk cell arrest in angiogenesis
Published in Nature communications (31-07-2015)“…Coordinated activity of VEGF and Notch signals guides the endothelial cell (EC) specification into tip and stalk cells during angiogenesis. Notch activation in…”
Get full text
Journal Article -
6
ALK1 Loss Results in Vascular Hyperplasia in Mice and Humans Through PI3K Activation
Published in Arteriosclerosis, thrombosis, and vascular biology (01-05-2018)“…OBJECTIVE—ALK1 (activin-receptor like kinase 1) is an endothelial cell-restricted receptor with high affinity for BMP (bone morphogenetic protein) 9 TGF-β…”
Get full text
Journal Article -
7
Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors
Published in Cancer cell (01-10-2005)“…Function-blocking antibodies to VEGF receptors R1 and R2 were used to probe their roles in controlling angiogenesis in a mouse model of pancreatic islet…”
Get full text
Journal Article -
8
Semaphorin 3A overcomes cancer hypoxia and metastatic dissemination induced by antiangiogenic treatment in mice
Published in The Journal of clinical investigation (01-05-2012)“…Cancer development, progression, and metastasis are highly dependent on angiogenesis. The use of antiangiogenic drugs has been proposed as a novel strategy to…”
Get full text
Journal Article -
9
The TGFβ pathway stimulates ovarian cancer cell proliferation by increasing IGF1R levels
Published in International journal of cancer (15-10-2016)“…In a search for new therapeutic targets for treating epithelial ovarian cancer, we analyzed the Transforming Growth Factor Beta (TGFβ) signaling pathway in…”
Get full text
Journal Article -
10
Incidence of diabetes mellitus and associated risk factors in the adult population of the Basque country, Spain
Published in Scientific reports (04-02-2021)“…The aim of this study was to estimate the incidence of diabetes mellitus in the Basque Country and the risk factors involved in the disease by reassessing an…”
Get full text
Journal Article -
11
TET2 controls chemoresistant slow-cycling cancer cell survival and tumor recurrence
Published in The Journal of clinical investigation (01-09-2018)“…Dormant or slow-cycling tumor cells can form a residual chemoresistant reservoir responsible for relapse in patients, years after curative surgery and adjuvant…”
Get full text
Journal Article -
12
Antitumor Effects of Anti-Semaphorin 4D Antibody Unravel a Novel Proinvasive Mechanism of Vascular-Targeting Agents
Published in Cancer research (Chicago, Ill.) (15-10-2019)“…One of the main consequences of inhibition of neovessel growth and vessel pruning produced by angiogenesis inhibitors is increased intratumor hypoxia. Growing…”
Get full text
Journal Article -
13
Therapeutic Benefit of Selective Inhibition of p110α PI3-Kinase in Pancreatic Neuroendocrine Tumors
Published in Clinical cancer research (01-12-2016)“…Mutations in the PI3K pathway occur in 16% of patients with pancreatic neuroendocrine tumors (PanNETs), which suggests that these tumors are an exciting…”
Get full text
Journal Article -
14
Inhibition of the p110α isoform of PI 3-kinase stimulates nonfunctional tumor angiogenesis
Published in The Journal of experimental medicine (23-09-2013)“…Understanding the direct, tumor cell-intrinsic effects of PI 3-kinase (PI3K) has been a key focus of research to date. Here, we report that cancer…”
Get full text
Journal Article -
15
Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing
Published in Proceedings of the National Academy of Sciences - PNAS (15-03-2011)“…MicroRNAs (miRNAs) are small RNA molecules that regulate gene expression at the posttranscriptional level and are critical for many cellular pathways. The…”
Get full text
Journal Article -
16
Neoadjuvant sunitinib plus exemestane in post-menopausal women with hormone receptor-positive/HER2-negative early-stage breast cancer (SUT_EXE-08): a phase I/II trial
Published in Scientific reports (09-10-2024)“…Neoadjuvant endocrine therapy (NET) for hormone receptor-positive (HR+) breast cancer might be as effective as chemotherapy, with a better toxicity profile…”
Get full text
Journal Article -
17
A Role for CXCR4 in Peritoneal and Hematogenous Ovarian Cancer Dissemination
Published in Molecular cancer therapeutics (01-02-2018)“…Epithelial ovarian cancer is characterized by a low recovery rate because the disease is typically diagnosed at an advanced stage, by which time most patients…”
Get full text
Journal Article -
18
Antiangiogenic Resistance: Novel Angiogenesis Axes Uncovered by Antiangiogenic Therapies Research
Published in Current drug targets (01-01-2016)“…The mechanisms of tumor growth and progression involve the activation of different processes such as neovascularization and angiogenesis. These processes…”
Get more information
Journal Article -
19
Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination
Published in The Journal of experimental medicine (2013)“…Therapy-induced resistance remains a significant hurdle to achieve long-lasting responses and cures in cancer patients. We investigated the long-term…”
Get full text
Journal Article -
20
Sunitinib Inhibits Tumor Growth and Synergizes with Cisplatin in Orthotopic Models of Cisplatin-Sensitive and Cisplatin-Resistant Human Testicular Germ Cell Tumors
Published in Clinical cancer research (15-05-2009)“…Purpose: Germ cell tumors (GCT) of the testis are highly curable, but those patients who are refractory to cisplatin (CDDP)-based combination chemotherapy have…”
Get full text
Journal Article